Pulse Biosciences (NASDAQ:PLSE) Issues Quarterly Earnings Results

Pulse Biosciences (NASDAQ:PLSE) released its quarterly earnings results on Wednesday. The company reported ($0.21) EPS for the quarter, RTT News reports. During the same period in the prior year, the firm posted ($0.19) earnings per share.

Pulse Biosciences Stock Performance

NASDAQ PLSE traded down $1.74 during trading on Thursday, hitting $15.98. The stock had a trading volume of 57,044 shares, compared to its average volume of 199,607. The stock has a market capitalization of $979.41 million, a price-to-earnings ratio of -20.01 and a beta of 1.74. Pulse Biosciences has a one year low of $4.24 and a one year high of $22.69. The stock has a 50 day simple moving average of $17.70 and a 200 day simple moving average of $14.22.

Wall Street Analysts Forecast Growth

Separately, StockNews.com raised shares of Pulse Biosciences to a “sell” rating in a research note on Friday, September 20th.

About Pulse Biosciences

Pulse Biosciences, Inc operates as a novel bioelectric medicine company. The company offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology.